Skip to content
OpenCapital
Get started

PROCEPT BioRobotics Corporation PRCT Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

UFP Technologies logo
UFP TechnologiesUFPT
$387K+212%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-22.5%
Enterprise value$1.25B—
P/S3.7×—

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's increase (decrease) in contract liabilities and current deferred income?
PROCEPT BioRobotics Corporation (PRCT) reported increase (decrease) in contract liabilities and current deferred income of $628K in Q1 2026.
How has PROCEPT BioRobotics Corporation's increase (decrease) in contract liabilities and current deferred income changed year-over-year?
PROCEPT BioRobotics Corporation's increase (decrease) in contract liabilities and current deferred income increased by 167.2% year-over-year, from $235K to $628K.
What is the long-term trend for PROCEPT BioRobotics Corporation's increase (decrease) in contract liabilities and current deferred income?
Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's increase (decrease) in contract liabilities and current deferred income has grown at a 43.1% compound annual growth rate (CAGR), from $792K to $3.32M.